EcoDrugPlus

Glutamate Ionotropic Receptor Ampa Type Subunit 4

Ensembl ID : ENSEEUG00000011106
Gene Symbol: GRIA4
1 External references
254 Possible Orthologues:

Glutamate Ionotropic Receptor Nmda Type Subunit 2b

Ensembl ID : ENSEEUG00000008704
Gene Symbol: GRIN2B
1 External references
335 Possible Orthologues:

Glutamate Ionotropic Receptor Nmda Type Subunit 2c

Ensembl ID : ENSEEUG00000008339
Gene Symbol: GRIN2C
1 External references
318 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 1

Ensembl ID : ENSEEUG00000000343
Gene Symbol: GRIK1
1 External references
316 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 2

Ensembl ID : ENSEEUG00000001342
Gene Symbol: GRIK2
1 External references
333 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 3

Ensembl ID : ENSEEUG00000014794
Gene Symbol: GRIK3
1 External references
257 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 4

Ensembl ID : ENSEEUG00000010145
Gene Symbol: GRIK4
1 External references
263 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSEEUG00000012183
Gene Symbol: GRIK5
1 External references
302 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSEEUG00000011084
Gene Symbol: GRM2
1 External references
281 Possible Orthologues:

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSEEUG00000009410
Gene Symbol: GRM3
1 External references
213 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSEEUG00000008673
Gene Symbol: GRM4
1 External references
266 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSEEUG00000015734
Gene Symbol: GRM5
1 External references
278 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).